Limits on Biomedical Research: Whether, Why, and How
Date of Event
Biomedical research aims to advance our understanding of health and illness and identify ways to prevent, diagnose, treat, and ameliorate diseases. Yet, arguably, not all biomedical research that promises progress in understanding health and illness is justified. Join Christine Grady to explore issues of whether we should limit progress through biomedical research, the reasons that some progress through biomedical research should be limited, and how limitations would/should be applied. Research examples such as dual use research of concern, neuromodulation, and research with organoids will be considered.
Christine Grady is a nurse-bioethicist, senior investigator and Chief of the Department of Bioethics at the National Institutes of Health Clinical Center. Her research focuses on clinical research ethics, including informed consent, vulnerability, study design, and recruitment, international research ethics and on ethical issues faced by nurses and other healthcare providers.
Dr. Grady has authored more than 200 papers in the biomedical and bioethics literature and authored or edited several books, including The Oxford Textbook of Clinical Research Ethics.
She is an elected fellow of the Hastings Center and the American Academy of Nursing, a research fellow at Kennedy Institute of Ethics and an elected member of the National Academy of Medicine. Dr. Grady holds a BS in nursing and biology from Georgetown University, a MSN in community health nursing from Boston College, and a PhD in philosophy from Georgetown University.
The Oliver C. Schroeder, Jr. Scholar-in-Residence Lecture
limits on biomedical research; dual use of biomedical research; neuromodulation; research with organoids
Grady, Christine, "Limits on Biomedical Research: Whether, Why, and How" (2022). Conferences and Symposia. 980.